In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

As the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...

Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...

A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and ...

PhenQ contains Capsimax Powder and α-Lacys Reset®, both of which boost thermogenesis-your body's ability to generate heat and ...

The biosimilars segment, too, will see fresh launches including Bevacizumab in the US, and Semaglutide filings across developed and emerging markets, including India by calendar 2026.